Full Press Release Details
Ultragenyx Announces Departure of Chief Financial Officer.
RARE
Ultragenyx Announces Departure of Chief Financial Officer
Key Takeaway: Ultragenyx Announces Departure of Chief Financial Officer
Price reaction · baseline $33.72 (2022-11-09 close) · hit after-hours · clean, no other RARE news in the window
day 0 close · peak
+11.4%
day 1
+8.4%
day 3
+5.2%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+43%
120-day peak, hindsight
Typical move
2.9%
average across 6 past catalysts
Cash runway
~13 mo
Low dilution risk
Lead asset
BPS804
Phase 2 · Hypophosphatasia